108 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
and CKD EMPA-REG ... SGLT2i in HF and CKD ... DAPA-CKD - Dapagliflozin ... visualabstract #table ... #CVD #CKD
Definitions of AKI, CKD, AKD
Acute Kidney Injury (AKI):
 • Increase in SCr by 2 50% within
Definitions of AKI, CKD ... Kidney Disease (CKD ... per 1.73 m2 • Stable ... /CKD • No structural ... damage #AKI #CKD
Oral Antihypertensive Medications - Selection by Comorbidities
Comorbidities: 
 • Stable Angina, HFpEF, HFrEF, AFib, TAA/Marfan, Aortic
Comorbidities: • Stable ... Dissection • CKD ... , DM, ESRD, PKD ... #pharmacology #table
Causes of Polyneuropathy - Differential Diagnosis Algorithm
 • Metabolic: DM, Hypothyroidism, CKD, Cirrhosis, Nutritional deficiency
 •
Causes of Polyneuropathy ... Hypothyroidism, CKD ... Paraneoplastic, CTD ... Diagnosis #Algorithm #causes
Adjusted Pain Medication Dosing based on GFR

#Renal #Dosing #Pain #Pharmacology #Opiates #CKD #Gabapentin #Table
Pharmacology #Opiates #CKD ... #Gabapentin #Table
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
Renal #Impairment #CKD ... #Table #GFR #Hypoglycemics
Antiarrhythmic Medication Table

#Antiarrhythmic #Medications #Table #Classification #Classes #Cardiology #Pharmacology
Antiarrhythmic Medication Table ... #Medications #Table ... #Classification ... #Classes #Cardiology
Hyperparathyroidism classification
Different causes and features of hyperparathyroidism - raised parathormone (PTH).

#Diagnosis #Hyperparathyroidism #Differential #Primary #Secondary #Tertiary
Hyperparathyroidism classification ... Different causes ... Tertiary #Comparison #Table ... #Classification
Algorithmic Approach to Acute Interstitial Nephritis
When to suspect AIN? (not sensitive)
 • AKI, AKD, rapidly progressive
sensitive) • AKI, AKD ... rapidly progressive CKD ... sterile pyuria, WBC casts ... proteinuria, granular casts
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Medications Summary Table ... Improved outcomes in CKD ... #medications #table